Feezo Chem. Formulation Private Limited

Feezo Chem. Formulation Private Limited - pharma in Kanpur, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24110UP2005PTC029888 Incorporated 28 April 2005 ROC Kanpur HQ Kanpur, Uttar Pradesh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹3.72 Cr
▼ 17% YoY
Net profit · FY 2025
₹33,331
Net margin 0.1%
EBITDA · FY 2025
₹33.34 Lakh
EBITDA margin 9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹23 Lakh
Issued & subscribed
Open charges
₹6.35 Cr
Satisfied ₹10.25 Lakh
Company age
21 yrs
Est. 2005
Directors on board
4
As per MCA filings

About Feezo Chem. Formulation Private Limited

Data last updated:

Feezo Chem. Formulation Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24110UP2005PTC029888. Its GSTIN is 05AACCF7979G1ZB (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹23 Lakh. It is led by directors including Karan Miglani and Geetika Miglani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 120/91 Lajpat Nagar, Kanpur, Uttar Pradesh, India – 208005.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.72 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹33,331 (net margin 0.1%) and EBITDA of ₹33.34 Lakh (EBITDA margin 9%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 8% over five years.

As per MCA filings, the company has open charges of ₹6.35 Cr and satisfied charges of ₹10.25 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹22 Lakh; the latest was in December 2016. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Panasia Herbal Private Limited with revenue of ₹3.75 Cr. The company has 6 MSME Form 1 returns on record between 2018 and 2023, listing 23 overdue payments to 12 micro and small suppliers.

Feezo Chem. Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-12-0013011). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24110UP2005PTC029888
Registration Number 029888
Incorporation Date 28 April 2005
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-12-0013011
Key People
Karan Miglani Director Geetika Miglani Director Pawan Miglani Director

Recognitions & Rankings of Feezo Chem. Formulation

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UK-12-0013011

Contact details

Feezo Chem. Formulation Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    120/91 Lajpat Nagar, Kanpur, Uttar Pradesh, India – 208005
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Feezo Chem. Formulation Private Limited, buy the company report.

Comprehensive company report
Feezo Chem. Formulation Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Feezo Chem. Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Feezo Chem. Formulation Private Limited, buy the company report.

Financials of Feezo Chem. Formulation Private Limited

FY 2025 filings available

Feezo Chem. Formulation Private Limited reported revenue of ₹3.72 Cr (down 17% YoY) for FY 2025.

Revenue · FY 2025
₹3.72 Cr ▼ 17%
Net profit · FY 2025
₹33,331 margin 0.1%
EBITDA · FY 2025
₹33.34 Lakh margin 9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 26%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 16%
5 years · compounded
▼ 4%

Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 17% fall in the latest year. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹33.34 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹33,331
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9%
Net Profit Margin0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Feezo Chem. Formulation Private Limited, buy the company report.

Board of directors of Feezo Chem. Formulation Private Limited

Feezo Chem. Formulation has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Karan MiglaniDirector29 Jun 201214 Years 4 MonthsCurrent
Geetika MiglaniDirector28 Mar 200620 Years 7 MonthsCurrent
Pawan MiglaniDirector28 Apr 200521 Years 6 MonthsCurrent
Harsh KumarDirector28 Apr 200521 Years 6 MonthsCurrent
View all directors

Peer comparison

Feezo Chem. Formulation Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Panasia Herbal Private Limited₹3.75 Cr (FY 2025)-17.0%Madhya Pradesh, India
Agati Healthcare Private Limited₹3.73 Cr (FY 2024)172.0%Navi Mumbai, Maharashtra, India
Nikol Formulation Private Limited₹3.72 Cr (FY 2024)40.0%Talod, Gujarat, India
Feezo Chem. Formulation Private Limitedthis company₹3.72 Cr (FY 2025)₹33,3310.1%-17.0%Kanpur, Uttar Pradesh, India
Aquadry Pharma Private Limited₹3.71 Cr (FY 2023)125.0%Mumbai, Maharashtra, India
Nutra Marck Life Sciences Private Limited₹3.71 Cr (FY 2025)0.0%Karnal, Haryana, India

To see the full peer comparison of Feezo Chem. Formulation Private Limited, buy the company report.

Auditor

Feezo Chem. Formulation Private Limited is audited by SUDHINDRA JAIN & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SUDHINDRA JAIN & CO.FY 2023001614C

Shareholding

The shareholding of Feezo Chem. Formulation Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Feezo Chem. Formulation Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6.35 Cr
Satisfied charges
₹10.25 Lakh
Breakdown by lending institutions
Others₹6.35 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Sep 200810131890Others₹6.35 CrOpen
16 Oct 2017100147703Others₹10.25 LakhSatisfied

To see the full charge records of Feezo Chem. Formulation Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Feezo Chem. Formulation Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹22 Lakh; the latest was in December 2016.

Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹22 Lakh

Deals on record (4 of 4)

WhenDealAmountParties
Dec 2016Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 3 individuals
Mar 2011Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Silpi Vyapaar Private Limited, an individual
Mar 2009Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Feb 2008Funding round₹22 LakhInvestors: Silpi Vyapaar Private Limited, 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Feezo Chem. Formulation Private Limited has 6 MSME Form 1 returns on record between 2018 and 2023, listing 23 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 12)

SupplierAmount dueDue sinceReported on
an individual supplier
Shreepati Pharmaceuticals Pvt Ltd
Indo Pack Limited
Shree Ganesh Industries
Arlavya Labels Private Limited

To see the full MSME payment records of Feezo Chem. Formulation Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Feezo Chem. Formulation has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
05AACCF7979G1ZBUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Feezo Chem. Formulation Private Limited, buy the company report.

Recent activity

Feezo Chem. Formulation Private Limited has 6 board changes on record since 2005: 5 appointments and 1 cessation. The latest: Krishan Miglani ceased to be Director on 31 Dec 2016.

AGM
Feezo Chem. Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 6.35 Cr registered on 27 Sep 2008 with Charge ID 10131890 was modified on 12 Sep 2025.
Filing
Feezo Chem. Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge registered on 16 Oct 2017 via Charge ID 100147703 with Others was fully satisfied on 14 Mar 2023.
Charges
A charge with Others amounted to Rs. 0.10 Cr with Charge ID 100147703 was registered on 16 Oct 2017.
Ceased
Krishan Miglani ceased to be Director.
Appointed
Karan Miglani was appointed as Director.
Charges
A charge with Others amounted to Rs. 6.35 Cr with Charge ID 10131890 was registered on 27 Sep 2008.
Appointed
Geetika Miglani was appointed as Director.
Appointed
Harsh Kumar was appointed as Director.
Appointed
Krishan Miglani was appointed as Director.
Appointed
Pawan Miglani was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Feezo Chem. Formulation is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 2005 (21+ years old) and is registered under CIN U24110UP2005PTC029888.

Feezo Chem. Formulation has 4 current directors:

The latest financial statements of Feezo Chem. Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Feezo Chem. Formulation is 05AACCF7979G1ZB, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Feezo Chem. Formulation is U24110UP2005PTC029888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Feezo Chem. Formulation has 1 court case on record: 1 filed by the company. 1 is pending.

Feezo Chem. Formulation was incorporated on 28 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Kanpur.

Feezo Chem. Formulation has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹22 Lakh; the latest was in December 2016.

The peers of Feezo Chem. Formulation by revenue are Panasia Herbal Private Limited, Agati Healthcare Private Limited, Nikol Formulation Private Limited, Aquadry Pharma Private Limited, Nutra Marck Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Krishan Miglani ceased to be Director on 31 Dec 2016. Karan Miglani was appointed as Director on 29 Jun 2012. Geetika Miglani was appointed as Director on 28 Mar 2006. Feezo Chem. Formulation has 6 board changes on record in total.

Yes, Feezo Chem. Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-UK-12-0013011).

Feezo Chem. Formulation has 6 MSME Form 1 returns on record between 2018 and 2023, listing 23 overdue payments to 12 micro and small suppliers. The latest return was filed on 31 Aug 2023.